Cell membrane-specific self-assembly of peptide nanomedicine induces tumor immunogenic death to enhance cancer therapy.

Abstract

Immunogenic cell death (ICD), as an unusual cell death pattern, mediates cancer cells to release a series of damage-associated molecular patterns (DAMPs), and is widely used in the field of cancer immunotherapy. Injuring the cell membrane can serve as a novel ICD initiation strategy. In this study, a peptide nanomedicine (PNpC) is designed using the fragment CM11 of cecropin, which is effective in disrupting cell membranes because of its α-helical structure. PNpC self-assembles in situ in the presence of high levels of alkaline phosphatase (ALP) on the tumor cell membrane, transforming from nanoparticles to nanofibers, which reduces the cellular internalization of the nanomedicine and increases the interaction between CM11 and tumor cell membranes. Both in vitro and in vivo results indicate that PNpC plays a significant role in killing tumor cells by triggering ICD. The ICD induced by the destruction of the cancer cell membrane is accompanied by the release of DAMPs, which promotes the maturation of DCs and facilitates the presentation of tumor-associated antigens (TAA), resulting in the infiltration of CD8+ T cells. We believe that PNpC can trigger ICD while killing cancer cells, providing a new reference for cancer immunotherapy.

• Authors: Pengsheng Fan, Yinghua Guan, Xiaoying Zhang, Jiaqi Wang, Yinsheng Xu, Benli Song, Suling Zhang, Hao Wang, Ya Liu, Zeng-Ying Qiao
• Journal: Nanoscale horizons (Nanoscale Horiz) Vol. 8 Issue 9 Pg. 1226-1234 (08 21 2023) ISSN: 2055-6764 [Electronic] England
• PMID: 37366007 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antigens, Neoplasm

Topics

• Humans
• Nanomedicine
• CD8-Positive T-Lymphocytes
• Antigens, Neoplasm
• Neoplasms (drug therapy)
• Cell Membrane